Investigators believe triglyceride testing could improve viral sepsis risk more broadly based on study findings.
|Articles|February 13, 2008
Severe reactions in patients bolused with Baxter's heparin
Heparin multi-dose vials associated with allergic reactions.
Advertisement
Advertisement
Related to this article
Nicholas Rebold, PharmD, MPH, BCIDP, AAHIVP, explains how education eases inpatient switches, and how the protocol cuts costs and simplifies workflow.
Findings from a meta-analysis of over 125 clinical trials led the agency to require a class-wide label change.
Gilead’s current lenacapavir patent is what makes Dr Reddy’s Laboratories’ formulation tentative.
Mark Ey, RPh, from NCPA, joins to discuss the opportunities for independent pharmacies within the ACCESS to Pharmacy Care Program.
Researchers say this net loss is unlikely to reverse without state and federal policy changes, including PBM reform.
At the center of the debate are the growing number of manufacturer demands for claims data as a condition of 340B pricing.
Nicholas Rebold, PharmD, MPH, BCIDP, AAHIVP, discusses his team’s and patients’ experiences in a pharmacist-led antiretroviral initiative.
Advertisement
Advertisement
Trending on Drug Topics
1
High Triglycerides Independently Linked with Severe COVID-19 Death
2
US Lost Over 3000 Pharmacies From 2022 to 2024, Mostly Chains
3
FDA Adds NAION Eye Risk Warning to All GLP-1 Labels
4
FDA Grants Tentative Approval for First Generic Lenacapavir
5